Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

1.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

209
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
209
Inflammatory Response01:28

Inflammatory Response

2.2K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Subjective-Device-Estimated Sleep Discrepancies in Late-Life Depression: Agreement and Associated Factors.

Alpha psychiatry·2026
Same author

Assessment of disease activity control and evaluation strategy in patients with Takayasu arteritis undergoing cardiac surgery: a retrospective cohort study.

Frontiers in cardiovascular medicine·2026
Same author

Head-to-head Comparison of Multimodal Imaging for Prostate Cancer Detection and Local Staging with Whole-mount Histopathology Reference.

European urology oncology·2026
Same author

Differentiating Acute-onset Autoimmune Hepatitis From Drug-Induced Autoimmune-like Hepatitis: A Multicenter Study and Score Development.

Clinical reviews in allergy & immunology·2026
Same author

Unraveling Potassium Poisoning Mechanisms over Pt/TiO<sub>2</sub> Catalysts for Complete Propane Oxidation.

Inorganic chemistry·2026
Same author

Response to Letter to the Editor: Comment on "Anticancer Drugs Associated With Tumor Lysis Syndrome: Insights From the US Food and Drug Administration Adverse Event Reporting System".

Clinical therapeutics·2026

Related Experiment Video

Updated: Jul 31, 2025

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

3.0K

IL-26 modulates T cell function in autoimmune hepatitis.

Wei He1, Qi Wei Qian1, Qiao Yan Liu1

  • 1Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, National Health Council Key Laboratory of Digestive Diseases, State Key Laboratory for Oncogenes and Related Genes, Shanghai Institute of Digestive Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

Journal of Digestive Diseases
|May 8, 2023
PubMed
Summary
This summary is machine-generated.

Elevated interleukin-26 (IL-26) in autoimmune hepatitis (AIH) promotes T cell activation and cytotoxic function. This suggests IL-26 may be a therapeutic target for AIH liver injury.

Keywords:
autoimmune hepatitiscytotoxicityinterleukin-26proinflammatory

More Related Videos

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

19.3K
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

1.7K

Related Experiment Videos

Last Updated: Jul 31, 2025

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

3.0K
The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

19.3K
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

1.7K

Area of Science:

  • Immunology
  • Hepatology
  • Molecular Biology

Background:

  • Autoimmune hepatitis (AIH) is a T cell-mediated liver disease.
  • Interleukin-26 (IL-26) is a cytokine implicated in inflammation.
  • The role of IL-26 in AIH pathogenesis is not well understood.

Purpose of the Study:

  • To investigate the expression and function of IL-26 in AIH.
  • To determine the cellular sources of IL-26 in the liver during AIH.
  • To assess the impact of IL-26 on T cell responses in AIH.

Main Methods:

  • Immunohistochemistry and immunofluorescence staining of liver biopsies from AIH patients and controls.
  • Confocal microscopy to identify IL-26 producing cells.
  • Flow cytometry to analyze T cell activation and function after IL-26 stimulation.

Main Results:

  • IL-26 levels were significantly increased in AIH liver samples compared to controls.
  • Intrahepatic IL-26 expression correlated with disease severity.
  • Liver-infiltrating T cells (CD4+, CD8+) and macrophages were identified as sources of IL-26.
  • IL-26 stimulation enhanced CD4+ and CD8+ T cell activation, cytotoxicity, and pro-inflammatory responses.

Conclusions:

  • Elevated IL-26 in AIH promotes T cell activation and cytotoxic capacity.
  • IL-26 plays a significant role in the immunopathogenesis of AIH.
  • Targeting IL-26 may offer a novel therapeutic strategy for AIH.